Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)

Cancer Research

Volumn 56, Issue 16, 1996, Pages 3763-3770

  Henderson, Robert A ^a   Nimgaonkar, Maya T ^a   Watkins, Simon C ^a   Robbins, Paul D ^a   Ball, Edward D ^a   Finn, Olivera J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MUCIN; STEM CELL FACTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DENDRITIC CELL; ELECTRON MICROSCOPY; FLUORESCENCE ACTIVATED CELL SORTER; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE;

ANTIGENS, CD34; ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; DENDRITIC CELLS; GENETIC ENGINEERING; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0029740631     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Pardoll, D. M. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol., 13 399-415, 1995.
2. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K E., Ledbetter, J. A., McGowan, P , and Linsley, P. S Costimulation of anti-tumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71: 1093-1102, 1992.
3. Chen, L., Linsley, P S , and Hellstrom, K. E. Costimulation of T cells for tumor immunity. Immunol. Today, 14, 483-486, 1993.
4. Nabel, G. J , Nabel, E G., Yang, Z. Y., Fox, B. A., Plautz, G. E , Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A E Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad. Sci. USA, 90, 11307-11311, 1993
5. 1 Adv. Immunol., 62: 217-256, 1996.
6. Steinman, R M. The dendritic cell system and its role in immunogenicity Annu. Rev. Immunol., 9: 271-296, 1991.
7. Mayordomo, J. I, Zorina, T., Storkus, W. J , Zitvogel, L , Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T , Kast, W. M., DeLeo, A. B , and Lotze, M. T. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat. Med , 1: 1297-1302, 1995.
8. Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M , Bazin, H., Tielemans, F , Leo, O., Urbain, J , and Moser, M Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol., 24, 605-610, 1994.
9. Hsu, F J., Benike, C , Fagnoli, F , Liles, T M , Czerwinski, D , Taidi, B , Engleman, E. G., and Levy, R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med., 2: 52-58, 1995.
10. Taylor-Papadimitriou, J., and Epenetos, A. A Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol., 12 227-233, 1994
11. Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian-Blander, J., and Barratt-Boyes, S. M MUC-1 epithelial tumor-mucin-based immunity and cancer vaccines Immunol. Rev., 145 61-89, 1995.
12. Barnd, D. L., Lan, M., Metzgar, R. S , and Finn, O. J Specific MHC-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl Acad Sci USA, 86 7159-7163, 1989.
13. Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor-Papadimitriou, J , McKenzie, I. F., Bast, R. C., Jr., and Finn, O. J. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res , 51: 2908-2916, 1991
14. Ioannides, C G., Fisk, B., Jerome, K R., Irimura, T., Wharton, J. T., and Finn, O J. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J. Immunol., 151: 3693-3703, 1993.
15. Rughetti, A., Turchi, V., Ghetti, C. A., Scambia, G., Panici, P. B., Roncucci, G., Mancuso, S , Frati, L., and Nuti, M. Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res., 53: 2457-2459, 1993.
16. Kotera, Y., Fontenot, J. D., Pecher, G., Metzgar, R S., and Finn, O. J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients Cancer Res., 54: 2856-2860, 1994.
17. Jerome, K R., Domenech, N., and Finn, O. J Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J. Immunol., 151 1654-1662, 1993.
18. Pecher, G., and Finn, O. J. Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected EBV-immonalized autologous B cells. Proc Natl. Acad Sci. USA, 93: 1699-1704, 1996.
19. Robbins, P. D., Tahara, H , Mueller, G , Hung, G., Bahnson, A., Zitvogel, L., Galea-Lauri, J., Ohashi, T., Patrene, K., Boggs, S. S., Evans, C H , Barranger, J. A., and Lotze, M. T. Retroviral vectors for use in human gene therapy for cancer. Gaucher Disease, and arthritis. Ann. N. Y. Acad. Sci., 716 72-89, 1994.
20. Pear, W. S , Nolan, G. P., Scott, M. L , and Baltimore, D. Production of high-titer helper free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA, 90, 8392-8396, 1993.
21. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P , Levitsky, H., Brose, K., Jackson, V., Hamada, H , Pardoll, D., and Mulligan, R. M. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539-3543, 1993
22. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., and Banchereau, J GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.), 360: 258-261, 1992.
23. Sallusto, F., and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α J. Exp. Med., 179: 1109-1118, 1994.
24. Santiago-Schwartz, F., Rappa, D A., Laky, K., and Carsons, S. E. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis. Stem Cells, 13: 186-197, 1995.
25. Jerome, K. R., Bu, D., and Finn, O. J Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B cells and Burkitt's lymphoma transfected with epithelial mucin complementary DNA. Cancer Res., 52: 5985-5990, 1992.
26. Watkins, S. C., Slayter, H. S., and Codington, J. F. Intracellular pathway of a mucin-type membrane glycoprotein in mouse mammary tumor cells. Carbohydrate Res., 213 185-200, 1991.
27. Bramwell, M. E., Wiseman, G., and Shotton, D. M. Electron-microscopic studies of the CA antigen, epitectin. J. Cell Sci., 86: 249-261, 1986.
28. Ligtenberg, J L., Buijs, F., Vos, H. L , and Hilkens, J. Suppression of cellular aggregation by high levels of episialin Cancer Res., 52, 2318-2324, 1992.
29. van de Wiel-van Kemenade, E., Ligtenberg, M. J., de Boer, A. J., Buijs, F., Vos, H. L., Mehef, C. J., Hilkens, J., and Figdor, C. G Episialin (MUC-1) inhibits cytotoxic lymphocyte-target cell interaction J. Immunol., 151, 767-776, 1993
30. Alijagic, S , Moller, P., Artuc, M., Jurgovsky, K., Czarnetzki, B. M., and Schadendorf, D. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur. J Immunol., 25: 3100-3107, 1995.
31. Caux, C., Massacrier, C., Vanbervliet, B., DuBois, B., Van Kooten, C., Durand, I., and Banchereau, J Activation of human dendritic cells through CD40 cross-linking J. Exp. Med., 180: 1263-1272, 1994.
32. Pandey, P., Kharbanda, S , and Kufe, D. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res., 55: 4000-4003, 1995.
33. Doménech, N., Henderson, R. A , and Finn, O. J. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J. Immunol , 155: 4766-4774, 1995.